cyclohexanol has been researched along with Cannabis Abuse in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jay, TM; Krebs, MO; Le Pen, G; Lenkei, Z; Rame, M; Renard, J; Vitalis, T | 1 |
| Almela, P; Aracil-Fernández, A; Manzanares, J | 1 |
| Agosti, V; Bisaga, A; Brooks, DJ; Carpenter, KM; Levin, FR; Mariani, J; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
| Dervaux, A | 1 |
| Massi, P; Parolaro, D; Rubino, T; Viganò, D | 1 |
| Dar, MS; DeSanty, KP | 1 |
| Arnold, JC; Hunt, GE; Mallet, PE; McGregor, IS; Topple, AN | 1 |
| De Miguel, R; Fernández, B; Gomez, N; Guaza, C; Ramos, JA; Romero, EM; Sagredo, O; Urigüen, L; Viveros, MP | 1 |
1 trial(s) available for cyclohexanol and Cannabis Abuse
| Article | Year |
|---|---|
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride | 2013 |
7 other study(ies) available for cyclohexanol and Cannabis Abuse
| Article | Year |
|---|---|
Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex.
Topics: Animals; Blotting, Western; Cannabinoids; Chronic Disease; Cyclohexanols; Dendrites; Disease Models, Animal; Disks Large Homolog 4 Protein; Hippocampus; Intracellular Signaling Peptides and Proteins; Long-Term Potentiation; Male; Marijuana Abuse; Membrane Proteins; Microelectrodes; Prefrontal Cortex; Pyramidal Cells; Rats, Wistar; Synaptophysin; Vesicular Glutamate Transport Proteins | 2016 |
Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.
Topics: Analysis of Variance; Animals; Anticonvulsants; Anxiety; Behavior, Animal; Body Temperature; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Tolerance; Fructose; gamma-Aminobutyric Acid; Male; Marijuana Abuse; Mice; Models, Animal; Motor Activity; Nucleus Accumbens; Pregabalin; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Topiramate; Transcription, Genetic; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2013 |
[Cannabis dependence and social phobia].
Topics: Adult; Cyclohexanols; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Paroxetine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
Topics: Animals; Behavior, Animal; Brain; Cannabinoids; Cerebellum; Cerebral Cortex; Corpus Striatum; Cyclic AMP; Cyclohexanols; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Drug Tolerance; GTP-Binding Proteins; Hippocampus; Injections, Intraperitoneal; Male; Marijuana Abuse; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction | 2000 |
Involvement of the cerebellar adenosine A(1) receptor in cannabinoid-induced motor incoordination in the acute and tolerant state in mice.
Topics: Adenosine; Analgesics; Animals; Cannabinoids; Cerebellar Ataxia; Cerebellum; Cyclohexanols; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Male; Marijuana Abuse; Mice; Neurons; Phosphodiesterase Inhibitors; Psychomotor Performance; Receptors, Cannabinoid; Receptors, Drug; Receptors, Purinergic P1; Signal Transduction; Tritium; Xanthines | 2001 |
The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.
Topics: Analgesics; Animals; Behavior, Animal; Body Temperature; Brain; Cannabinoids; Catalepsy; Cell Count; Cyclohexanols; Dose-Response Relationship, Drug; Immunohistochemistry; Marijuana Abuse; Motor Activity; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Lew; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug | 2001 |
Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.
Topics: Analgesics; Animals; Behavior, Animal; Cannabinoids; Corticosterone; Cyclohexanols; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Grooming; Male; Marijuana Abuse; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Neostriatum; Neurosecretory Systems; Nociceptors; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sex Characteristics | 2002 |